Bioxcel therapeutics to present at the bofa securities 2023 health care conference

New haven, conn., may 02, 2023 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that vimal mehta, ph.d., ceo of bioxcel therapeutics, will participate in a fireside chat at the bofa securities 2023 health care conference in las vegas on tuesday, may 9, 2023 at 10:15 a.m. pt. he will be joined by robert risinger, m.d., chief medical officer, neuroscience, and matt wiley, chief commercial officer.
BTAI Ratings Summary
BTAI Quant Ranking